Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
Stefano Piaserico, Paolo Gisondi, Simone Cazzaniga, Luigi Naldi
Topics & Concepts
MedicinePsoriasisCoronavirus disease 2019 (COVID-19)CohortPharmacotherapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCohort studyRetrospective cohort studyDermatologyInternal medicineVirologyOutbreakDiseaseInfectious disease (medical specialty)Psoriasis: Treatment and PathogenesisCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts